Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

61,636 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Supervised machine learning algorithms demonstrate proliferation index correlates with long-term recurrence after complete resection of WHO grade I meningioma.
Nguyen MP, Morshed RA, Dalle Ore CL, Cummins DD, Saggi S, Chen WC, Choudhury A, Ravi A, Raleigh DR, Magill ST, McDermott MW, Theodosopoulos PV. Nguyen MP, et al. Among authors: chen wc. J Neurosurg. 2022 Jun 3;138(1):86-94. doi: 10.3171/2022.4.JNS212516. Print 2023 Jan 1. J Neurosurg. 2022. PMID: 36303473 Free PMC article.
Radiotherapy for meningiomas.
Chen WC, Perlow HK, Choudhury A, Nguyen MP, Mirchia K, Youngblood MW, Lucas CG, Palmer JD, Magill ST, Raleigh DR. Chen WC, et al. J Neurooncol. 2022 Nov;160(2):505-515. doi: 10.1007/s11060-022-04171-9. Epub 2022 Oct 31. J Neurooncol. 2022. PMID: 36315366 Free PMC article. Review.
A case (report) for mechanistic validation of meningioma molecular therapies.
Nguyen MP, Seo K, Eaton CD, Lucas CG, Chen WC, Choudhury A, Young JS, Raleigh DR. Nguyen MP, et al. Neurooncol Adv. 2022 Oct 8;4(1):vdac162. doi: 10.1093/noajnl/vdac162. eCollection 2022 Jan-Dec. Neurooncol Adv. 2022. PMID: 36382111 Free PMC article. No abstract available.
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses.
Raleigh D, Chen W, Choudhury A, Youngblood M, Polley MY, Lucas CH, Mirchia K, Maas S, Suwala A, Won M, Bayley J, Harmanci A, Harmanci A, Klisch T, Nguyen M, Vasudevan H, McCortney K, Yu T, Bhave V, Lam TC, Pu J, Leung G, Chang J, Perlow H, Palmer J, Haberler C, Berghoff A, Preusser M, Nicolaides T, Mawrin C, Agnihotri S, Resnick A, Rood B, Chew J, Young J, Boreta L, Braunstein S, Schulte J, Butowski N, Santagata S, Spetzler D, Bush NAO, Villanueva-Meyer J, Chandler J, Solomon D, Rogers C, Pugh S, Mehta M, Sneed P, Berger M, Horbinski C, McDermott M, Perry A, Bi W, Patel A, Sahm F, Magill S. Raleigh D, et al. Among authors: chen w. Res Sq [Preprint]. 2023 Mar 20:rs.3.rs-2663611. doi: 10.21203/rs.3.rs-2663611/v1. Res Sq. 2023. PMID: 36993741 Free PMC article. Updated. Preprint.
NOTCH3 drives meningioma tumorigenesis and resistance to radiotherapy.
Choudhury A, Cady MA, Lucas CG, Najem H, Phillips JJ, Palikuqi B, Zakimi N, Joseph T, Birrueta JO, Chen WC, Bush NAO, Hervey-Jumper SL, Klein OD, Toedebusch CM, Horbinski CM, Magill ST, Bhaduri A, Perry A, Dickinson PJ, Heimberger AB, Ashworth A, Crouch EE, Raleigh DR. Choudhury A, et al. bioRxiv [Preprint]. 2023 Jul 11:2023.07.10.548456. doi: 10.1101/2023.07.10.548456. bioRxiv. 2023. PMID: 37503127 Free PMC article. Updated. Preprint.
Molecular Features of Resected Melanoma Brain Metastases, Clinical Outcomes, and Responses to Immunotherapy.
Vasudevan HN, Delley C, Chen WC, Mirchia K, Pan S, Shukla P, Aabedi AA, Nguyen MP, Morshed RA, Young JS, Boreta L, Fogh SE, Nakamura JL, Theodosopoulos PV, Phillips J, Hervey-Jumper SL, Daras M, Pike L, Aghi MK, Tsai K, Raleigh DR, Braunstein SE, Abate AR. Vasudevan HN, et al. JAMA Netw Open. 2023 Aug 1;6(8):e2329186. doi: 10.1001/jamanetworkopen.2023.29186. JAMA Netw Open. 2023. PMID: 37589977 Free PMC article.
Radiotherapy and radiosurgery for meningiomas.
Chen WC, Lucas CG, Magill ST, Rogers CL, Raleigh DR. Chen WC, et al. Neurooncol Adv. 2023 Jun 3;5(Suppl 1):i67-i83. doi: 10.1093/noajnl/vdac088. eCollection 2023 May. Neurooncol Adv. 2023. PMID: 37711972 Free PMC article.
Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses.
Chen WC, Choudhury A, Youngblood MW, Polley MC, Lucas CG, Mirchia K, Maas SLN, Suwala AK, Won M, Bayley JC, Harmanci AS, Harmanci AO, Klisch TJ, Nguyen MP, Vasudevan HN, McCortney K, Yu TJ, Bhave V, Lam TC, Pu JK, Li LF, Leung GK, Chan JW, Perlow HK, Palmer JD, Haberler C, Berghoff AS, Preusser M, Nicolaides TP, Mawrin C, Agnihotri S, Resnick A, Rood BR, Chew J, Young JS, Boreta L, Braunstein SE, Schulte J, Butowski N, Santagata S, Spetzler D, Bush NAO, Villanueva-Meyer JE, Chandler JP, Solomon DA, Rogers CL, Pugh SL, Mehta MP, Sneed PK, Berger MS, Horbinski CM, McDermott MW, Perry A, Bi WL, Patel AJ, Sahm F, Magill ST, Raleigh DR. Chen WC, et al. Nat Med. 2023 Dec;29(12):3067-3076. doi: 10.1038/s41591-023-02586-z. Epub 2023 Nov 9. Nat Med. 2023. PMID: 37944590 Free PMC article.
Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.
Vasudevan HN, Payne E, Delley CL, John Liu S, Mirchia K, Sale MJ, Lastella S, Nunez MS, Lucas CG, Eaton CD, Casey-Clyde T, Magill ST, Chen WC, Braunstein SE, Perry A, Jacques L, Reddy AT, Pekmezci M, Abate AR, McCormick F, Raleigh DR. Vasudevan HN, et al. Nat Commun. 2024 Jan 12;15(1):477. doi: 10.1038/s41467-024-44755-9. Nat Commun. 2024. PMID: 38216572 Free PMC article.
61,636 results
You have reached the last available page of results. Please see the User Guide for more information.